ConductScience.org, home

Paper33249249

Co-adsorption of synthetic Mincle agonists and antigen to silica nanoparticles for enhanced vaccine activity: A formulation approach to co-delivery.

Abdelwahab WM and 6 others. Int J Pharm, 2021. Cited by 12 papers, by iCite.

Cite this record

ConductScience Library. Co-adsorption of synthetic Mincle agonists and antigen to silica nanoparticles for enhanced vaccine activity: A formulation approach to co-delivery. Papers, record 33249249. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33249249

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Co-adsorption of synthetic Mincle agonists and antigen to silica nanoparticles for enhanced vaccine activity: A formulation approach to co-delivery.
PubMed
Journal
Int J Pharm
PubMed
Year
2021
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
12
iCite
Relative citation ratio, by iCite
0.79
iCite
Revised in PubMed
2023-05-25
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Abdelwahab WMWalid M
2Riffey AAlexander
3Buhl CCassie
4Johnson CCraig
5Ryter KKendal
6Evans JTJay T
7Burkhart DJDavid J

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
NanoparticlesMajor topic
VaccinesMajor topic
Adsorption
Animals
Humans
Lectins, C-Type
Leukocytes, Mononuclear
Mice
Ovalbumin
Silicon Dioxide

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
HHSN272201400050CNIAID NIH HHSUnited StatesPubMedPubMed
P20 GM103546NIGMS NIH HHSUnited StatesP20GM103546PubMedNIH RePORTER

Download CSV of grants

References32

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
131809053Aryl Trehalose Derivatives as Vaccine Adjuvants for Mycobacterium tuberculosis.J Med Chem2020https://conductscience.org/library/papers/31809053PubMed
223138852Clinically-translated silica nanoparticles as dual-modality cancer-targeted probes for image-guided surgery and interventions.Integr Biol (Camb)2013https://conductscience.org/library/papers/23138852PubMed
325776964Use of a lipid-coated mesoporous silica nanoparticle platform for synergistic gemcitabine and paclitaxel delivery to human pancreatic cancer in mice.ACS Nano2015https://conductscience.org/library/papers/25776964PubMed
420417963The use of calcium phosphate nanoparticles encapsulating Toll-like receptor ligands and the antigen hemagglutinin to induce dendritic cell maturation and T cell activation.Biomaterials2010https://conductscience.org/library/papers/20417963PubMed
527343242Enhancement of ovalbumin-specific Th1, Th2, and Th17 immune responses by amorphous silica nanoparticles.Int J Immunopathol Pharmacol2016https://conductscience.org/library/papers/27343242PubMed
622246129C-type lectin receptor-induced NF-κB activation in innate immune and inflammatory responses.Cell Mol Immunol2012https://conductscience.org/library/papers/22246129PubMed
724757512Working together: interactions between vaccine antigens and adjuvants.Ther Adv Vaccines2013https://conductscience.org/library/papers/24757512PubMed
829121607Preparation of fluorescently labeled silica nanoparticles using an amino acid-catalyzed seeds regrowth technique: Application to latent fingerprints detection and hemocompatibility studies.J Colloid Interface Sci2018https://conductscience.org/library/papers/29121607PubMed
93742670Lipid polymorphism and the roles of lipids in membranes.Chem Phys Lipids1986https://conductscience.org/library/papers/3742670PubMed
1028759590Mixed Th1 and Th2 Mycobacterium tuberculosis-specific CD4 T cell responses in patients with active pulmonary tuberculosis from Tanzania.PLoS Negl Trop Dis2017https://conductscience.org/library/papers/28759590PubMed
1127108209Surface arming magnetic nanoparticles with amine N-halamines as recyclable antibacterial agents: Construction and evaluation.Colloids Surf B Biointerfaces2016https://conductscience.org/library/papers/27108209PubMed
1217127724Multiple roles of cord factor in the pathogenesis of primary, secondary, and cavitary tuberculosis, including a revised description of the pathology of secondary disease.Ann Clin Lab Sci2006https://conductscience.org/library/papers/17127724PubMed
1323582904Silica nanorattle with enhanced protein loading: a potential vaccine adjuvant.J Colloid Interface Sci2013https://conductscience.org/library/papers/23582904PubMed
1426072017Safety and immunogenicity of candidate vaccine M72/AS01E in adolescents in a TB endemic setting.Vaccine2015https://conductscience.org/library/papers/26072017PubMed
1518785685Comparison of cytotoxic and inflammatory responses of photoluminescent silicon nanoparticles with silicon micron-sized particles in RAW 264.7 macrophages.J Appl Toxicol2009https://conductscience.org/library/papers/18785685PubMed
1615197224The linkage of innate to adaptive immunity via maturing dendritic cells in vivo requires CD40 ligation in addition to antigen presentation and CD80/86 costimulation.J Exp Med2004https://conductscience.org/library/papers/15197224PubMed
1716369012Plasmid interleukin-23 (IL-23), but not plasmid IL-27, enhances the protective efficacy of a DNA vaccine against Mycobacterium tuberculosis infection.Infect Immun2006https://conductscience.org/library/papers/16369012PubMed
1825855371Synthesis and evaluation of trehalose-based compounds as novel inhibitors of cancer cell migration and invasion.Chem Biol Drug Des2015https://conductscience.org/library/papers/25855371PubMed
1923657437Mesoporous silica nanoparticles as antigen carriers and adjuvants for vaccine delivery.Nanoscale2013https://conductscience.org/library/papers/23657437PubMed
2029721531Extra-Large Pore Mesoporous Silica Nanoparticles Enabling Co-Delivery of High Amounts of Protein Antigen and Toll-like Receptor 9 Agonist for Enhanced Cancer Vaccine Efficacy.ACS Cent Sci2018https://conductscience.org/library/papers/29721531PubMed

See all 32 referencesDownload CSV of references

Cited by10

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 12 citations.

PMIDTitleJournalYearIn PapersSource
42028278Advancements in nanomaterial-based adjuvants for animal vaccines.Mater Today Bio2026https://conductscience.org/library/papers/42028278PubMed
41501246Unravelling mechanisms regulating Mincle activation.Commun Biol2026https://conductscience.org/library/papers/41501246PubMed
39771997Advancements in Nanoparticle-Based Adjuvants for Enhanced Tuberculosis Vaccination: A Review.Vaccines (Basel)2024https://conductscience.org/library/papers/39771997PubMed
39771982Recent Advances in the Development of Mincle-Targeting Vaccine Adjuvants.Vaccines (Basel)2024https://conductscience.org/library/papers/39771982PubMed
38844494Vaccination with Mincle agonist UM-1098 and mycobacterial antigens induces protective Th1 and Th17 responses.NPJ Vaccines2024https://conductscience.org/library/papers/38844494PubMed
38258117Co-Delivery of a Novel Lipidated TLR7/8 Agonist and Hemagglutinin-Based Influenza Antigen Using Silica Nanoparticles Promotes Enhanced Immune Responses.Pharmaceutics2024https://conductscience.org/library/papers/38258117PubMed
38250834Co-Delivery of Novel Synthetic TLR4 and TLR7/8 Ligands Adsorbed to Aluminum Salts Promotes Th1-Mediated Immunity against Poorly Immunogenic SARS-CoV-2 RBD.Vaccines (Basel)2023https://conductscience.org/library/papers/38250834PubMed
35076466Supramolecular Nanostructures for Vaccines.Biomimetics (Basel)2021https://conductscience.org/library/papers/35076466PubMed
35013704Emerging vaccine nanotechnology: From defense against infection to sniping cancer.Acta Pharm Sin B2022https://conductscience.org/library/papers/35013704PubMed
33752265Emerging glyco-based strategies to steer immune responses.FEBS J2021https://conductscience.org/library/papers/33752265PubMed

Download CSV of cited by

Genes11

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/33249249

GET https://conductscience.org/api/papers/v1/33249249/references?page=2